113 related articles for article (PubMed ID: 28588780)
21. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
[TBL] [Abstract][Full Text] [Related]
22. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
24. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
25. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
Lee J; Cho J; Chang JH; Suh CO
Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
[TBL] [Abstract][Full Text] [Related]
26. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.
Tsuchida K; Murakami N; Kato T; Okuma K; Okamoto H; Kashihara T; Takahashi K; Inaba K; Igaki H; Nakayama Y; Nakano T; Itami J
J Radiat Res; 2019 Oct; 60(5):650-657. PubMed ID: 31251358
[TBL] [Abstract][Full Text] [Related]
27. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy.
Kim HK; Thornton AF; Greenberg HS; Page MA; Junck L; Sandler HM
Am J Clin Oncol; 1997 Aug; 20(4):358-63. PubMed ID: 9256889
[TBL] [Abstract][Full Text] [Related]
28. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
29. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
30. Re-irradiation in locally recurrent lung cancer patients.
Schlampp I; Rieber J; Adeberg S; Bozorgmehr F; Heußel CP; Steins M; Kappes J; Hoffmann H; Welzel T; Debus J; Rieken S
Strahlenther Onkol; 2019 Aug; 195(8):725-733. PubMed ID: 30937509
[TBL] [Abstract][Full Text] [Related]
31. Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy : TROD 09-001 multi-institutional study.
Ozyigit G; Onal C; Igdem S; Alicikus ZA; Iribas A; Akin M; Yalman D; Cetin I; Aksu MG; Atalar B; Dincbas F; Hurmuz P; Guler OC; Aydin B; Sert F; Yildirim C; Gorken IB; Agaoglu FY; Korcum AF; Yuce D; Ozkok S; Darendeliler E; Akyol F
Strahlenther Onkol; 2019 Oct; 195(10):882-893. PubMed ID: 31143994
[TBL] [Abstract][Full Text] [Related]
32. Robotic stereotactic irradiation and reirradiation for spinal metastases: safety and efficacy assessment.
Wang Q; Song Y; Zhuang H; Wang X; Li F; Dong Y; Wang J; Yuan Z
Chin Med J (Engl); 2014; 127(2):232-8. PubMed ID: 24438609
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
Kim HJ; Chang JS; Koom WS; Lee KC; Kim GE; Kim YB
Gynecol Oncol; 2018 Nov; 151(2):208-214. PubMed ID: 30195468
[TBL] [Abstract][Full Text] [Related]
34. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group.
Ikushima H; Wakatsuki M; Ariga T; Kaneyasu Y; Tokumaru S; Isohashi F; Ii N; Uno T; Ohno T; Arisawa K; Toita T
Int J Clin Oncol; 2018 Apr; 23(2):314-320. PubMed ID: 29086206
[TBL] [Abstract][Full Text] [Related]
36. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
37. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
